News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
WUXI BIO Up 5% as Nomura Says Reiterated Full-yr Revenue Growth Guidance and Buyback Are Positive Signals of Undervaluation
WUXI BIO (02269.HK) opened 1.08% higher today (1st) and once soared 6.4% in early trading to a peak of HKD35.46. It last traded at HKD35.02, up 5.04%, with 18.7564 million shares t...
Reset
Send
The window will close in 5 seconds
WUXI BIO Up 5% as Nomura Says Reiterated Full-yr Revenue Growth Guidance and Buyback Are Positive Signals of Undervaluation
Close
Recommend
7
Positive
6
Negative
0
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

WUXI BIO (02269.HK)  +1.300 (+3.899%)    Short selling $164.88M; Ratio 18.662%   opened 1.08% higher today (1st) and once soared 6.4% in early trading to a peak of HKD35.46. It last traded at HKD35.02, up 5.04%, with 18.7564 million shares traded, involving HKD658 million.

Nomura believed that, together with the plan announced earlier this week to repurchase up to 407 million shares for no more than USD400 million, this voluntary business update demonstrates solid operations and signals that the stock is undervalued.

Management also provided high revenue growth targets for 2027-29, with encouraging trends in manufacturing revenue, a key market focus. WUXI BIO's share price has lost 17% over the past 60 days, compared with a 5% decline in the HSI over the same period.

Therefore, the buyback and business update represent a positive signal from management regarding undervaluation. Nomura maintained its Buy rating with an unchanged TP of HKD50.54.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-06-01 12:25.)

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.